Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

Comirnaty targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 subvariant ...

BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

It’s been over four years since the beginning of the COVID-19 pandemic. And since then, the virus has changed substantially.

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...

PFE along with BioNTech SE BNTX announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

He feels the company has a sensible strategy to regain its footing somewhat after the years of the COVID-19 pandemic when Comirnaty (co-developed with German peer BioNTech) was a vaccine used to ...